Implantation Tool for Cartilage Trimming and Solid Substrate Fit
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for treating cartilage and bone defects, such as osteoarthritis and osteochondral disorders, face challenges in achieving site-specific tissue growth and reconstruction due to mechanical instability of natural scaffolds and immunological reactivity of synthetic materials, while requiring a perfect topographic match for joint grafting.
Innovation Solution
The use of optimized solid substrates with a specific height and fit within the implantation site, characterized by a press fit with respect to length and width, and a height approximately 2 mm below the articular cartilage layer, combined with a biocompatible polymer layer to fill the void, promotes cell and tissue growth.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If natural polymer scaffolds are used for tissue engineering, then cell interaction and biocompatibility are improved, but mechanical stability deteriorates
Solution Approach 1:
The patent employs composite materials by combining natural polymers (collagen, alginate, hyaluronic acid, or chitosan) with synthetic polymers (polyethylene glycol, poly-L-lactic acid, poly-D,L-lactic acid, or caprolactone). This composite approach allows the scaffold to simultaneously achieve the biocompatibility and cell interaction properties of natural materials while gaining the mechanical stability and structural integrity of synthetic materials, thereby resolving the contradiction between biocompatibility and mechanical stability.
2Strength
If synthetic materials are used as substrates for tissue assembly, then mechanical strength is improved, but immunological reactivity and toxicity increase
Solution Approach 1:
The patent uses composite materials combining synthetic and natural polymers to reduce immunological reactivity while maintaining mechanical strength. The natural polymer component (collagen, alginate, hyaluronic acid, or chitosan) provides biocompatibility and reduces immune response, while the synthetic polymer component (polyethylene glycol, poly-L-lactic acid, poly-D,L-lactic acid, or caprolactone) contributes mechanical strength and structural stability.
Solution Approach 2:
The patent applies local quality by creating regions with different material compositions within the scaffold. The scaffold contains both natural and synthetic polymer phases, where the natural polymer regions provide biocompatibility and cell interaction, while the synthetic polymer regions provide mechanical support. This spatial differentiation of material properties allows the scaffold to simultaneously achieve strength and low immunogenicity.
3Reliability
If autologous tissue grafting is performed, then biocompatibility is improved, but morbidity and surgical complexity increase
Solution Approach 1:
The patent applies self-service by using the patient's own stem cells (autologous stem cells) to populate the implantable composition. The scaffold is designed to support and guide the differentiation of these patient-derived stem cells into the desired tissue type, eliminating the need for complex tissue harvesting and processing procedures while maintaining full biocompatibility. The composition essentially serves itself by providing the structural framework and biochemical cues needed for the patient's own cells to generate the repair tissue.
4Strength
If chemical modification is applied to natural scaffolds to improve mechanical strength, then strength is improved, but toxicity increases
Solution Approach 1:
The patent avoids chemical modification of natural scaffolds by instead using physical blending and crosslinking of natural and synthetic polymers. The composite material system allows mechanical strength to be achieved through the inherent properties of the synthetic polymer component and the physical interactions between polymer phases, rather than through chemical modification of the natural polymer, thereby avoiding the introduction of toxic chemicals.
Solution Approach 2:
The patent replaces chemical modification mechanisms with physical and structural mechanisms to achieve mechanical strength. Instead of chemically altering natural polymers to improve strength, the invention uses the physical presence of synthetic polymer components, phase separation, and physical crosslinking to provide mechanical support, thereby avoiding toxic chemical agents.
Data Source
AI summary
This invention provides methods for optimal implantation of a solid substrate for promoting cell or tissue growth or restored function in an osteochondral, bone or cartilage tissue in a subject in need thereof. The methods include selecting and preparing a solid substrate for promoting cell or tissue growth or restored function for implantation, which solid substrate has a length and width or that promotes a tight fit within the boundaries of the implantation site and is further characterized by a height sufficient such that when a first terminus of said solid substrate is implanted within a bone in a site for implantation, a second terminus of said solid substrate is at a height at least 2 mm less than an articular cartilage layer surface or is proximal to a tide mark region in said implantation site and optionally applying a biocompatible polymer layer to an apical surface of said implant, which layer does not exceed the articular cartilage layer surface in height. Tools for implementation of optimal positioning are described including a unique tool (5-120) for trimming cartilage at the implantation site.